Intersphincteric resection for low rectal cancer: an overview
- PMID: 22778935
- PMCID: PMC3384981
- DOI: 10.1155/2012/241512
Intersphincteric resection for low rectal cancer: an overview
Abstract
The treatment of rectal cancer has evolved from being solely a surgical endeavor to a multidisciplinary practice. Despite the improvement in outcomes conferred by the addition of chemoradiation therapy to rectal cancer treatment, advances in surgical technique have significantly increased rates of sphincter preservation and the avoidance of a permanent stoma. In recent years, intersphincteric resection for low rectal cancer has been offered and performed in patients as an alternative to abdominoperineal resection. An overview of this procedure, including indications, oncological and functional results based on current literature, is presented herein.
References
-
- Heald RJ, Ryall RDH. Recurrence and survival after total mesorectal excision for rectal cancer. The Lancet. 1986;1(8496):1479–1482. - PubMed
-
- MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. The Lancet. 1993;341(8843):457–460. - PubMed
-
- Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. The New England Journal of Medicine. 2004;351(17):1731–1740. - PubMed
-
- Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. The New England Journal of Medicine. 1997;336:980–987. published correction appears in The New England Journal of Medicine, vol. 336, pp 1539, 1997. - PubMed
LinkOut - more resources
Full Text Sources
